IDYA Stock: Price, Earnings History and SEC Filings
IDEAYA Biosciences, Inc. (IDYA) last traded at $31.96, down 2.83% on the latest session and down 16.8% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $-1.22 against an analyst estimate of $-1.18, a miss of 3.4%.
$31.96 -2.83%
1 month-16.81%
52-week high$42.68
52-week low$26.81
Volume838,033
ExchangeNasdaqGS
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
IDYA earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 4, 2026 | $-1.22 | $-1.18 | -3.39% |
| Mar 2026 | May 5, 2026 | $-1.11 | $-1.07 | -3.74% |
| Dec 2025 | Feb 17, 2026 | $-0.94 | $-1.03 | +8.74% |
IDYA beat the analyst EPS estimate in 1 of its last 3 reported quarters. Source: Nasdaq.
Latest SEC filings for IDYA
SEC filing data is not available right now. You can search for IDYA on SEC EDGAR.
IDYA news
- Is IDEAYA Biosciences (IDYA) A Bargain Following Its ESMO 2026 Clinical Data?Oct 31, 2026 · finance.yahoo.com
- IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)Oct 30, 2026 · finance.yahoo.com
- Earnings Preview: Acadia Pharmaceuticals (ACAD) Q3 Earnings Expected to DeclineOct 28, 2026 · finance.yahoo.com
- IDEAYA Biosciences, Inc. (IDYA) Expected to Beat Earnings Estimates: Can the Stock Move Higher?Oct 27, 2026 · finance.yahoo.com
- IDE849 (SHR-4849) DLL3 TOP1 ADC Updated Phase 1 Results at ESMO 2026 Demonstrates Promising Anti-Tumor Activity and Preliminary Overall Survival Results in Relapsed Small Cell Lung Cancer and Neuroendocrine CarcinomasOct 23, 2026 · finance.yahoo.com
- William Blair Expands Biotech Research as Veteran Analyst Alethia Young Initiates CoverageOct 21, 2026 · finance.yahoo.com
- IDEAYA Biosciences and Servier Announce Data From Three Clinical Trials at ESMO 2026 Supporting the Potential of Darovasertib to Become a Foundational New Therapy for Patients Across the Treatment Journey of Uveal MelanomaOct 19, 2026 · finance.yahoo.com
About IDEAYA Biosciences, Inc.
IDEAYA Biosciences, Inc. (IDYA) is a US-listed public company on Nasdaq.